USD
+$0.00
(+0.00%
)At Close (As of Sep 9, 2025)
$1.37B
Market Cap
-
P/E Ratio
-1.56
EPS
$34.13
52 Week High
$10.87
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $468M |
Total Revenue | $605M |
Cost Of Revenue | $137M |
Costof Goods And Services Sold | $137M |
Operating Income | -$170M |
Selling General And Administrative | $190M |
Research And Development | $210M |
Operating Expenses | $639M |
Investment Income Net | - |
Net Interest Income | $40M |
Interest Income | $23M |
Interest Expense | $12M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $11M |
Income Before Tax | -$131M |
Income Tax Expense | $37M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$169M |
Comprehensive Income Net Of Tax | - |
Ebit | -$119M |
Ebitda | -$108M |
Net Income | -$169M |
Field | Value (USD) |
---|---|
Total Assets | $1.2B |
Total Current Assets | $1.1B |
Cash And Cash Equivalents At Carrying Value | $164M |
Cash And Short Term Investments | $164M |
Inventory | $35M |
Current Net Receivables | $99M |
Total Non Current Assets | $134M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $796M |
Other Current Assets | $9.5M |
Other Non Current Assets | - |
Total Liabilities | $881M |
Total Current Liabilities | $756M |
Current Accounts Payable | $105M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $566M |
Total Non Current Liabilities | $124M |
Capital Lease Obligations | $28M |
Long Term Debt | $97M |
Current Long Term Debt | $558M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $683M |
Other Current Liabilities | $71M |
Other Non Current Liabilities | $18K |
Total Shareholder Equity | $360M |
Treasury Stock | - |
Retained Earnings | -$1.2B |
Common Stock | - |
Common Stock Shares Outstanding | $108M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$26M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | -$14M |
Capital Expenditures | $43M |
Change In Receivables | - |
Change In Inventory | $2.6M |
Profit Loss | - |
Cashflow From Investment | -$140M |
Cashflow From Financing | $90M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$169M |
Field | Value (USD) |
---|---|
Gross Profit | $468M |
Total Revenue | $605M |
Cost Of Revenue | $137M |
Costof Goods And Services Sold | $137M |
Operating Income | -$170M |
Selling General And Administrative | $190M |
Research And Development | $210M |
Operating Expenses | $639M |
Investment Income Net | - |
Net Interest Income | $40M |
Interest Income | $23M |
Interest Expense | $12M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $11M |
Income Before Tax | -$131M |
Income Tax Expense | $37M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$169M |
Comprehensive Income Net Of Tax | - |
Ebit | -$119M |
Ebitda | -$108M |
Net Income | -$169M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
NovoCure Limited, an oncology company, is engaged in the development, manufacture and marketing of Optune for the treatment of a variety of solid tumors. The company is headquartered in Saint Helier, Jersey.